Erlotinib Terminated Phase 1 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Advanced Solid Malignancies Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02080078A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline